Latest News

 Hims & Hers Super Bowl Ad for Semaglutide "Nothing Short of Reckless," Says Partnership for Safe Medicines / image credit Partnership for Safe Medicines
Hims & Hers Super Bowl Ad for Semaglutide "Nothing Short of Reckless," Says Partnership for Safe Medicines

February 7th 2025

In letters to the FDA and Fox Broadcasting, PSM enumerated the laws abrogated and the potential harms of the ad being viewed by 200 million people on February 9, 2025.

Diabetes Caution: FDA Warns of Risk of Missing Critical Alerts from Smartphone-Compatible Diabetes Devices / image credit ©Yurii/stock.adobe.com
Diabetes Caution: FDA Warns of Risk of Missing Critical Alerts from Smartphone-Compatible Diabetes Devices

February 6th 2025

Viking Therapeutics Advances 3 Potential Obesity Treatments Based on Promising 2024 Clinical Trial Results
Viking Therapeutics Advances 3 Potential Obesity Treatments Based on Promising 2024 Clinical Trial Results

February 6th 2025

Premature menopause may increase risk for t2d
Premature Menopause May Increase Risk of Type 2 Diabetes Suggests Study of 1.1 Million Women

February 5th 2025

Enobosarm Preserves Lean Body Mass in Older Adults Treated with Semaglutide for Weight Reduction / image credit ©CLIPAREA_Custom Media/Shutterstock.com
Enobosarm Preserves Lean Body Mass in Older Adults Treated with Semaglutide for Weight Reduction: Topline Phase 2b Data

January 27th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.